Find a Trial
Trial Summary
Protocol No. | C16-174 | ||
---|---|---|---|
Status | OPEN TO ACCRUAL | ||
Principal Investigator | Adra, Nabil | ||
Scope | National | ||
Phase | Phase III | ||
Age Group | Adult | ||
Title | DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC) | ||
Description | The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. | ||
Key Eligibility | In order to be eligible to take part in this trial, patients must meet the following criteria: | ||
Applicable Disease Sites | Prostate | ||
Participating Institutions | Indiana University (IU) | ||
Treatment Type | Treatment | ||
Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu |